News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Grais Linda
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/16/2023 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Bought 10,000 shares
@ $2.45, valued at
$24.5k
|
|
12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/15/2022 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.965, valued at
$14.5k
|
|
06/17/2022 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $0.9899, valued at
$14.8k
|
|
09/13/2021 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $2.6, valued at
$39k
|
|
07/01/2021 |
4
| Grais Linda (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Disposed/sold 9,683 shares
@ $0 |
|
06/16/2021 |
4
| Grais Linda (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $2.74, valued at
$41.1k
|
|
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/12/2020 |
4
| Grais Linda S (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.
Txns:
| Granted 15,000 options to buy
@ $3.27, valued at
$49.1k
|
|
06/05/2020 |
4
| Grais Linda S (Director) has filed a Form 4 on Zosano Pharma Corp
Txns:
| Granted 15,000 options to buy
@ $1.01, valued at
$15.2k
|
|
06/05/2020 |
4
| Grais Linda S (Director) has filed a Form 4 on Zosano Pharma Corp
Txns:
| Granted 15,000 options to buy
@ $1.01, valued at
$15.2k
|
|
05/20/2020 |
4
| Grais Linda S (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 1,324 shares
@ $0 |
|
03/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/05/2019 |
4
| Grais Linda S (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 1,436 shares
@ $0 |
|
01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/16/2019 |
4
| Grais Linda S (Director) has filed a Form 4 on Zosano Pharma Corp
Txns:
| Granted 25,000 options to buy
@ $2.56, valued at
$64k
|
|
01/16/2019 |
3
| Grais Linda S (Director) has filed a Form 3 on Zosano Pharma Corp |
06/25/2018 |
4
| Grais Linda S (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 1,307 shares
@ $0 |
|
03/05/2018 |
4
| Grais Linda S (Director) has filed a Form 4 on ARCA biopharma, Inc.
Txns:
| Granted 8,000 options to buy
@ $0.72, valued at
$5.8k
|
|
12/11/2017 |
4
| Grais Linda S (President and CEO) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Disposed/sold 230,000 shares
@ $1.52, valued at
$349.6k
Disposed/sold 70,000 shares
@ $1.52, valued at
$106.4k
Disposed/sold 289,200 options to buy
@ $2.15, valued at
$621.8k
Disposed/sold 348,600 options to buy
@ $2.98, valued at
$1M
Disposed/sold 160,000 options to buy
@ $3.76, valued at
$601.6k
Disposed/sold 491,550 options to buy
@ $7.38, valued at
$3.6M
Disposed/sold 37,500 options to buy
@ $7.84, valued at
$294k
Disposed/sold 30,826 options to buy
@ $0.67, valued at
$20.7k
Disposed/sold 30,827 options to buy
@ $0.67, valued at
$20.7k
Disposed/sold 11,969 options to buy
@ $0.67, valued at
$8k
|
|
07/14/2017 |
4
| Grais Linda S (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 1,318 shares
@ $0 |
|
03/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/08/2016 |
4
| Grais Linda S (President and CEO) has filed a Form 4 on Ocera Therapeutics, Inc. |
06/20/2016 |
4
| Grais Linda S (Director) has filed a Form 4 on PRA Health Sciences, Inc.
Txns:
| Granted 1,466 shares
@ $0 |
|
03/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/30/2013 |
4
| Grais Linda S (Director) has filed a Form 4 on ARCA biopharma, Inc.
Txns:
| Granted 583 options to buy
@ $1.4, valued at
$816.2 |
|
|
|
|